INSM

INSMED INC

INSM·457669307·US·Common Stock·Healthcare - Biotechnology-13D/G

INSM (INSMED INC) is held by 262 institutional investors as of Q2 2026. Largest holders: FMR LLC ($1.7B), BlackRock, Inc. ($1.7B), VANGUARD PORTFOLIO MANAGEMENT LLC ($1.1B). Net institutional sentiment: Mixed. In Q2 2026, 1 member of Congress and 146 funds bought INSM.

262
Holders
(20 Elite)
$19.9B
Total Value
52% (281)
Consensus
146 buying - 135 selling
13F: Insider & Congress: Updated regularly
INSM

Smart Money Verdict

View all
Loading verdict
Held by 262 funds
20 elite

Who's Trading

Source dates: Price Aug 28, 2026 · Insiders Aug 19, 2026 · Activists Aug 14, 2026 · Congress Jul 7, 2026

InsiderSMSHAROKY MELVIN MDSell $638KAug 17, 2026
ActivistDGDarwin Global Management, Ltd.3.0%Aug 14, 2026
InsiderARAdsett RogerSell $32.0MAug 10, 2026
Checking access…

Top Holders

Checking access…
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
16.1M(+22.7%)$1.7B0.1%+5.41%
39
Decreased
15.8M(-5.2%)$1.7B0.0%+25.90%
0
Increased
10.4M(+0.3%)$1.1B0.1%-15.30%
32
Decreased
10.4M(-56.8%)$1.1B0.1%-0.21%
0
Increased
9.8M(+1.5%)$1B0.0%-15.03%
32
Increased
8.8M(+18.5%)$937.8M4.7%+42.34%
69
Increased
8.2M(+47.2%)$878.3M0.2%+54.81%
52
Increased
6.2M(+102.1%)$658.9M0.1%+37.73%
61
Increased
6.1M(+224.5%)$647.9M2.2%+8.26%
87
Increased
6.1M(+9.0%)$645.3M0.0%+56.59%
34
Increased
5.9M(+4.5%)$626.7M0.3%+4.06%
39
Decreased
5.4M(-16.6%)$580.2M0.9%+16.40%
0
Unchanged
4.8M$516.3M4.4%+34.92%
0
Decreased
4.2M(-5.2%)$448.8M0.0%+88.47%
0
Increased
2.6M(+48.8%)$275.6M0.0%+1.05%
42
Increased
2.6M(+17.1%)$272.6M0.0%+4.58%
36
Decreased
2.3M(-13.1%)$242.4M0.1%+99.71%
0
New
2.2M$229.3M2.0%+16.67%
79
Increased
2M(+76.9%)$218.4M0.1%+26.66%
46
Increased
1.7M(+1032.8%)$179.4M0.2%+12.89%
59

Showing 1-20 of 289

1 / 15
INSMINSMINSMED INC

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used